What is the Ocrevus co-pay program?
If eligible commercially insured patients need assistance with their out-of-pocket drug and/or infusion costs, your OCREVUS Patient Navigator can help them enroll in the OCREVUS Co-pay Program.* *Eligibility criteria apply.
What is Ocrevus used to treat?
OCREVUS is a prescription medicine used to treat: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults Primary progressive MS, in adults. It is not known if OCREVUS is safe and effective in children.
How do I qualify for free Ocrevus If I have insurance?
If you have health insurance for your medicine, you must have already tried other types of patient assistance to qualify for free OCREVUS from the Genentech Patient Foundation. This includes the OCREVUS Co-pay Card and support from independent co-pay assistance foundations. You must also meet financial criteria.
How can Ocrevus help uninsured or underinsured patients?
Uninsured patients and insured patients without coverage for their medicine must meet a different set of income requirements. Your Patient Navigator can help eligible commercially insured patients enroll in the OCREVUS Co-pay Program for help with their out-of-pocket drug costs, infusion costs or both.*
How do people afford Ocrevus?
If you have Medicare Part B and supplemental insurance, most or all of your OCREVUS costs will be covered by the plan. If you have Medicare Advantage, plan designs and out-of-pocket expenses may vary depending on your other healthcare expenses and whether you have hit your out-of-pocket maximum.
Does Ocrevus have copay assistance?
OCREVUS Co-pay Program Genentech co-pay programs provide financial assistance to eligible commercially insured patients to help with their co-pays, co-insurance, or other out-of-pocket (OOP) costs. Patients who qualify can receive up to $21,000 in assistance per 12-month period.
How do I use my Ocrevus copay card?
The OCREVUS Co-pay Program verifies the patient's information and notifies your practice when the card is loaded with the proper amount. Collect the patient's $5 co-pay for drug costs and/or $5 co-pay for infusion costs, then collect the rest of the patient's out-of-pocket costs for drug and/or infusion using the card.
What is the Genentech Patient Foundation?
The Genentech Patient Foundation gives free Genentech medicine to people who don't have insurance coverage or who have financial concerns.
Is there a generic for OCREVUS?
Ocrevus, whose generic name is ocrelizumab, also is approved to treat patients who have relapsing-remitting MS.
How good is OCREVUS?
Ocrevus is a highly effective (category 2.0) DMD; in clinical trials people taking Ocrevus had about 50% fewer relapses than people taking Rebif . During the clinical trials, Ocrevus appeared to reduce disability progression and significantly reduce the number of lesions seen on MRI scans compared to Rebif.
What is the J code for OCREVUS?
Drug: HCPCSCODEDESCRIPTIONJ2350Injection, ocrelizumab, 1 mg
Does OCREVUS cause headaches?
Infusion side effects can occur during or up to 24 hours after an Ocrevus infusion. This may also be called an infusion reaction. Examples of infusion side effects that Ocrevus can cause include: headache.
Who is eligible for OCREVUS?
Patients are eligible if they: Have been prescribed OCREVUS for an FDA-approved indication. Are 18 years of age or older, or have a caregiver or have a legally authorized person to manage the patient's co-pay assistance. Have commercial (private or non-governmental) insurance.
What drugs does Genentech make?
Our Medicines & ProductsMedicines.Actemra® (TOCILIZUMAB [authorized for Emergency Use])Actemra® (tocilizumab)Activase® (alteplase)Alecensa® (alectinib)Avastin® (bevacizumab)Boniva Tablets® (ibandronate sodium)Cathflo Activase® (alteplase)More items...
What is the difference between OCREVUS and Kesimpta?
Both Ocrevus and Kesimpta target the CD20 antigen on B cells. Ocrevus is given intravenously by a healthcare practitioner every six months in the maintenance phase, while patients self-administer under-the-skin Kesimpta at home once monthly during maintenance.
What is the cost of OCREVUS in Canada?
The cost of Ocrevus is set at approximately $33,000 per year. Much of the cost can be reimbursed through private and group health plans for people who meet the prescribing criteria and through provincial drug programs for individuals who meet the prescribing criteria.
What is the J code for OCREVUS?
Drug: HCPCSCODEDESCRIPTIONJ2350Injection, ocrelizumab, 1 mg
How often is OCREVUS given?
OCREVUS is an infusion that is given every 6 months. These infusions can be given at an infusion center, your doctor's office, or at home, depending on what you and your doctor decide is right for you. Your first dose will be split between 2 treatments, for a total of 3 treatments your first year.
How to report Ocrevus side effects?from ocrevus.com
These are not all the possible side effects of OCREVUS. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. For more information, go to www.OCREVUS.com or call 1-844-627-3887.
What is Genentech copay?from ocrevus-hcp.com
Genentech co-pay programs provide financial assistance to eligible commercially insured patients to help with their co-pays, co-insurance, or other out-of-pocket (OOP) costs.
How long after ocrevus infusion do you have to be monitored?from ocrevus.com
You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction. Tell your healthcare provider or nurse if you get any of these symptoms: These infusion reactions can happen for up to 24 hours after your infusion.
What is access solutions?from ocrevus-hcp.com
Access Solutions is committed to helping your patients access the Genentech medicines they need, providing assistance to your patients after OCREVUS is prescribed. For more information, download the Patient Navigator Roadmap or reach out to a Patient Navigator by calling 1-844-627-3887.
What to do if you have a baby and you have ocrevus?from ocrevus.com
If you have a baby and you received OCREVUS during your pregnancy, it is important to tell your baby’s healthcare provider about receiving OCREVUS so they can decide when your baby should be vaccinated. are pregnant, think that you might be pregnant, or plan to become pregnant.
How long after birth control can you use ocrevus?from ocrevus.com
It is not known if OCREVUS will harm your unborn baby. You should use birth control (contraception) during treatment with OCREVUS and for 6 months after your last infusion of OCREVUS. Talk with your healthcare provider about what birth control method is right for you during this time. Pregnancy Registry.
What does a patient navigator do?from genentech-access.com
Your Patient Navigator can refer you to patient assistance options to help you afford the medicine you need.
How to contact Genentech about Ocrevus?
Medicine Information Support. Ask about possible side effects and any other medical questions related to your prescribed Genentech medicine. Call us at (800) 821-8590, Monday-Friday, 5am-5pm PT. Chat with us using our live chat feature, Monday-Friday, 5am-5pm PT.
What to tell your healthcare provider before taking Ocrevus?
Before receiving OCREVUS, tell your healthcare provider about all of your medical conditions, including if you: have ever taken, take, or plan to take medicines that affect your immune system, or other treatments for MS. have ever had hepatitis B or are a carrier of the hepatitis B virus.
How long after ocrevus infusion do you have to be monitored?
You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction. Tell your healthcare provider or nurse if you get any of these symptoms: These infusion reactions can happen for up to 24 hours after your infusion.
What to do if you have a baby and you have Ocrevus?
If you have a baby and you received OCREVUS during your pregnancy, it is important to tell your baby’s healthcare provider about receiving OCREVUS so they can decide when your baby should be vaccinated.
What is the phone number for Genentech?
Call us at (877) 436-3683 or (877) GENENTECH, Monday-Friday, 6am-5pm PT. This service offers coverage support, patient assistance, and other useful information. Provides free medicine to patients without insurance coverage or who can't pay for their Genentech medicine. Provides additional resources and information.
Can you take ocrevus if you are allergic to it?
Do not receive OCREVUS if you have had a life-threatening allergic reaction to OCREVUS. Tell your healthcare provider if you have had an allergic reaction to OCREVUS or any of its ingredients in the past.
Is ocrevus safe for children?
Primary progressive MS, in adults. It is not known if OCREVUS is safe and effective in children.
What is Genentech Patient Foundation?
The Genentech Patient Foundation helps people affected by serious medical conditions get the Genentech medicine they have been prescribed. If patients don’t have insurance coverage or have financial concerns and meet eligibility criteria, they may be able to get free medicine from the Genentech Patient Foundation.
What is Genentech copay?
Genentech co-pay programs provide financial assistance to eligible commercially insured patients to help with their co-pays, co-insurance, or other out-of-pocket (OOP) costs.
Does Genentech offer assistance?
Genentech offers a variety of assistance options for your patients, based on certain eligibility criteria. Use the chart below to determine which assistance program may be right for your patient. *Eligibility criteria apply. Not valid for patients using federal or state government programs to pay for their medications.
When should ocrevus be discontinued?
If serious herpes infections occur, OCREVUS should be discontinued or withheld until the infection has resolved, and appropriate treatment should be administered.
Is there any data on the developmental risk associated with Ocrevus?
There are no adequate data on the developmental risk associated with use of OCREVUS in pregnant women. There are no data on B-cell levels in human neonates following maternal exposure to OCREVUS. However, transient peripheral B-cell depletion and lymphocytopenia have been reported in infants born to mothers exposed to other anti-CD20 antibodies during pregnancy. OCREVUS is a humanized monoclonal antibody of an immunoglobulin G1 subtype and immunoglobulins are known to cross the placental barrier.
Does Ocrevus cause breast cancer?
An increased risk of malignancy with OCREVUS may exist. In controlled trials, malignancies, including breast cancer, occurred more frequently in OCREVUS-treated patients. Breast cancer occurred in 6 of 781 females treated with OCREVUS and none of 668 females treated with REBIF or placebo. Patients should follow standard breast cancer screening guidelines.
Can you use ocrevus after immunosuppressive therapy?
When initiating OCREVUS after an immunosuppressive therapy or initiating an immunosuppressive therapy after OCREVUS, consider the potential for increased immunosuppressive effect. OCREVUS has not been studied in combination with other MS therapies.
Does Ocrevus work for hepatitis B?
Perform HBV screening in all patients before initiation of treatment with OCREVUS. Do not administer OCREVUS to patients with active HBV confirmed by positive results for HBsAg and anti-HB tests. For patients who are negative for surface antigen [HBsAg] and positive for HB core antibody [HBcAb+] or are carriers of HBV [HBsAg+], consult liver disease experts before starting and during treatment.
Can a herpes infection occur with ocrevus?
Serious cases of infections caused by herpes simplex virus and varicella zoster virus, including central nervous system infections (encephalitis and meningitis), intraocular infections, and disseminated skin and soft tissue infections, have been reported in the postmarketing setting in multiple sclerosis patients receiving OCREVUS. Serious herpes virus infections may occur at any time during treatment with OCREVUS. Some cases were life-threatening.
Does ocrevus cause infections?
A higher proportion of OCREVUS- treated patients experienced infections compared to patients taking REBIF or placebo. In RMS trials, 58% of OCREVUS-treated patients experienced one or more infections compared to 52% of REBIF-treated patients. In the PPMS trial, 70% of OCREVUS-treated patients experienced one or more infections compared to 68% of patients on placebo. OCREVUS increased the risk for upper respiratory tract infections, lower respiratory tract infections, skin infections, and herpes-related infections. OCREVUS was not associated with an increased risk of serious infections in MS patients. Delay OCREVUS administration in patients with an active infection until the infection is resolved.
How often is ocrevus given?
OCREVUS is approved by the FDA to treat relapsing or primary progressive forms of multiple sclerosis (MS). OCREVUS is given once every six months by an intravenous (IV) infusion. 1. FIRST AND ONLY approved disease-modifying therapy for primary progressive multiple sclerosis (PPMS), a highly disabling form of MS 1,2.
What is the purpose of Ocrevus?
(ocrelizumab) About OCREVUS. OCREVUS ® (ocrelizumab) is a therapeutic monoclonal antibody that represents a different scientific approach to treating MS. It targets a type of immune cell called a CD20-positive B cell that plays a key role in the disease. OCREVUS is approved by the FDA to treat relapsing ...
How long after ocrevus infusion do you have to be monitored?
You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction. Tell your healthcare provider or nurse if you get any of these symptoms: itchy skin. rash. hives.
What are the side effects of Ocrevus?
These may include problems with thinking, balance, eyesight, weakness on 1 side of your body, strength, or using your arms or legs . Hepatitis B virus (HBV) reactivation: Before starting treatment with OCREVUS, your healthcare provider will do blood tests to check for hepatitis B viral infection.
Is Ocrevus approved by the FDA?
The FDA approval of OCREVUS is based on positive results from three Phase III studies (OPERA I and OPERA II in RMS; ORATORIO in PPMS).
Can you get Ocrevus with PML?
Progressive Multifocal Leukoencephalopathy ( PML): Although no cases have been seen with OCREVUS treatment in clinical trials, PML may happen with OCREVUS. PML is a rare brain infection that usually leads to death or severe disability. Tell your healthcare provider right away if you have any new or worsening neurologic signs or symptoms. These may include problems with thinking, balance, eyesight, weakness on 1 side of your body, strength, or using your arms or legs.
Can you take ocrevus if you are allergic to it?
Do not receive OCREVUS if you have had a life-threatening allergic reaction to OCREVUS. Tell your healthcare provider if you have had an allergic reaction to OCREVUS or any of its ingredients in the past.
How to contact Ocrevus?
For more information, go to www.OCREVUS.comor call 1-844-627-3887.
Who owns the OCREVUS logo?
OCREVUS®and its logo are registered trademarks of Genentech, Inc.
How long after ocrevus infusion do you have to be monitored?
You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction.
Is ocrevus safe for children?
Primary progressive MS, in adults. It is not known if OCREVUS is safe and effective in children.
Can you delay treatment with ocrevus?
Your healthcare provider should delay your treatment with OCREVUS until your infection is gone. Decreased immunoglobulins: OCREVUS may cause a decrease in some types of immunoglobulins. Your healthcare provider will do blood tests to check your blood immunoglobulin levels.
Does ocrevus cause skin infections?
Infection: OCREVUS increases your risk of getting upper respiratory tract infections, lower respiratory tract infections, skin infections, and herpes infections. Infections are a common side effect, which can be serious. Tell your healthcare provider right away if you have an infection.
What is the registry for Ocrevus?
Pregnancy Registry. There is a pregnancy registry for women who take OCREVUS during pregnancy. If you become pregnant while receiving OCREVUS, tell your healthcare provider right away. Talk to your healthcare provider about registering with the OCREVUS Pregnancy Registry. The purpose of this registry is to collect information about your health and your baby’s health. Your healthcare provider can enroll you in this registry by calling 1-833-872-4370 or visiting www.ocrevuspregnancyregistry.com.
How long after ocrevus infusion do you have to be monitored?
You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction. Tell your healthcare provider or nurse if you get any of these symptoms: These infusion reactions can happen for up to 24 hours after your infusion.
What to do if you have a baby and you have ocrevus?
If you have a baby and you received OCREVUS during your pregnancy, it is important to tell your baby’s healthcare provider about receiving OCREVUS so they can decide when your baby should be vaccinated. are pregnant, think that you might be pregnant, or plan to become pregnant.
How long after birth control can you use ocrevus?
It is not known if OCREVUS will harm your unborn baby. You should use birth control (contraception) during treatment with OCREVUS and for 6 months after your last infusion of OCREVUS. Talk with your healthcare provider about what birth control method is right for you during this time. Pregnancy Registry.
When should you get your Ocrevus shots?
When possible, you should receive any ‘non-live’ vaccines at least 2 weeks before you start treatment with OCREVUS. If you would like to receive any non-live (inactivated) vaccines, including the seasonal flu vaccine, while you are being treated with OCREVUS, talk to your healthcare provider.
Does Ocrevus slow down the rate of infusion?
If you get infusion reactions, your healthcare provider may need to stop or slow down the rate of your infusion. Infection: OCREVUS increases your risk of getting upper respiratory tract infections, lower respiratory tract infections, skin infections, and herpes infections.
Can you take ocrevus if you are allergic to it?
Do not receive OCREVUS if you have had a life-threatening allergic reaction to OCREVUS. Tell your healthcare provider if you have had an allergic reaction to OCREVUS or any of its ingredients in the past.
What is the registry for Ocrevus?
Pregnancy Registry. There is a pregnancy registry for women who take OCREVUS during pregnancy. If you become pregnant while receiving OCREVUS, tell your healthcare provider right away. Talk to your healthcare provider about registering with the OCREVUS Pregnancy Registry. The purpose of this registry is to collect information about your health and your baby’s health. Your healthcare provider can enroll you in this registry by calling 1-833-872-4370 or visiting www.ocrevuspregnancyregistry.com.
What to tell your healthcare provider before taking Ocrevus?
Before receiving OCREVUS, tell your healthcare provider about all of your medical conditions, including if you: have ever taken, take, or plan to take medicines that affect your immune system, or other treatments for MS. have ever had hepatitis B or are a carrier of the hepatitis B virus.
How long after ocrevus infusion do you have to be monitored?
You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction. Tell your healthcare provider or nurse if you get any of these symptoms: itchy skin. rash. hives.
What to do if you have a baby and you have ocrevus?
If you have a baby and you received OCREVUS during your pregnancy, it is important to tell your baby’s healthcare provider about receiving OCREVUS so they can decide when your baby should be vaccinated. are pregnant, think that you might be pregnant, or plan to become pregnant.
When should you get your Ocrevus shots?
When possible, you should receive any ‘non-live’ vaccines at least 2 weeks before you start treatment with OCREVUS. If you would like to receive any non-live (inactivated) vaccines, including the seasonal flu vaccine, while you are being treated with OCREVUS, talk to your healthcare provider.
Can you take ocrevus if you are allergic to it?
Do not receive OCREVUS if you have had a life-threatening allergic reaction to OCREVUS. Tell your healthcare provider if you have had an allergic reaction to OCREVUS or any of its ingredients in the past.
Is ocrevus safe for children?
Primary progressive MS, in adults. It is not known if OCREVUS is safe and effective in children.
How to contact Ocrevus?
For more information, go to www.OCREVUS.com or call 1-844-627-3887.
What is ocrevus used for?
What is OCREVUS? OCREVUS is a prescription medicine used to treat: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Primary progressive MS, in adults. It is not known if OCREVUS is safe and effective in children.
What is the most important information I should know about OCREVUS?
Infusion reactions: Infusion reactions are a common side effect of OCREVUS, which can be serious and may require you to be hospitalized. You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction.
Can you delay treatment with ocrevus?
Your healthcare provider should delay your treatment with OCREVUS until your infection is gone. Decreased immunoglobulins: OCREVUS may cause a decrease in some types of immunoglobulins. Your healthcare provider will do blood tests to check your blood immunoglobulin levels.
Does ocrevus cause skin infections?
Infection: OCREVUS increases your risk of getting upper respiratory tract infections, lower respiratory tract infections, skin infections, and herpes infections. Infections are a common side effect, which can be serious. Tell your healthcare provider right away if you have an infection.
Does ocrevus cause cancer?
OCREVUS may cause serious side effects, including: Risk of cancers (malignancies) including breast cancer. Follow your healthcare provider’s instructions about standard screening guidelines for breast cancer. These are not all the possible side effects of OCREVUS. Call your doctor for medical advice about side effects.
